Home
>
National Drug Code (NDC)
>
COPAXONE
COPAXONE - 68546-317-30 - (glatiramer acetate)
Drug Information of COPAXONE
| Product NDC: | 68546-317 |
| Proprietary Name: | COPAXONE |
| Non Proprietary Name: | glatiramer acetate |
| Active Ingredient(s): | 20 mg/mL & nbsp; glatiramer acetate |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of COPAXONE
| Product NDC: | 68546-317 |
| Labeler Name: | Teva Neuroscience, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020622 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20080428 |
Package Information of COPAXONE
| Package NDC: | 68546-317-30 |
| Package Description: | 30 BLISTER PACK in 1 CARTON (68546-317-30) > 1 SYRINGE, GLASS in 1 BLISTER PACK > 1 mL in 1 SYRINGE, GLASS |
NDC Information of COPAXONE
| NDC Code | 68546-317-30 |
| Proprietary Name | COPAXONE |
| Package Description | 30 BLISTER PACK in 1 CARTON (68546-317-30) > 1 SYRINGE, GLASS in 1 BLISTER PACK > 1 mL in 1 SYRINGE, GLASS |
| Product NDC | 68546-317 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | glatiramer acetate |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20080428 |
| Marketing Category Name | NDA |
| Labeler Name | Teva Neuroscience, Inc. |
| Substance Name | GLATIRAMER ACETATE |
| Strength Number | 20 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |
